Sangamo Therapeutics Inc (SGMO) — Cash Flow Reinvestment Rate
Sangamo Therapeutics Inc (SGMO) has a Cash Flow Reinvestment Rate of 0.03x as of September 2024, reinvesting $348.00K (capex $115.00K plus investments $233.00K) from operating cash flow of $11.76 Million. Explore Sangamo Therapeutics Inc (SGMO) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sangamo Therapeutics Inc Cash Flow Reinvestment Rate (2017–2020)
Historical reinvestment intensity for Sangamo Therapeutics Inc across 3 annual periods. Also explore SGMO total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sangamo Therapeutics Inc (2017–2020)
Year-by-year capital reinvestment analysis for Sangamo Therapeutics Inc. For live market cap and broader valuation context, see SGMO market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 1.59x | $270.92 Million | $169.88 Million | $14.71 Million | ▼ -42.2% |
| 2018 | 2.76x | $102.46 Million | $37.15 Million | $43.06 Million | ▼ -60.2% |
| 2017 | 6.92x | $77.40 Million | $11.18 Million | $3.75 Million | — |